UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

Annals of oncology, 2020-05, Vol.31 (5), p.569-581

2020

Volltextzugriff (PDF)

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Annals of oncology, 2017-11, Vol.28 (11), p.2768-2772

2017

Volltextzugriff (PDF)

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

Annals of oncology, 2021-08, Vol.32 (8), p.1005-1014

2021

Volltextzugriff (PDF)

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

Annals of oncology, 2013-03, Vol.24 (3), p.618-624

2013

Volltextzugriff (PDF)

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients

European journal of nuclear medicine and molecular imaging, 2012-05, Vol.39 (5), p.852-863

2012

Volltextzugriff (PDF)

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial

Annals of oncology, 2023-06, Vol.34 (6), p.531-542

2023

Volltextzugriff (PDF)

New method for producing power electronic circuit boards by cold-gas spraying and investigation of adhesion mechanisms

Surface & coatings technology, 2010-11, Vol.205 (4), p.1115-1118

2010

Volltextzugriff (PDF)

The use of ultrasonic cavitation for near-surface structuring of robust and low-cost AlNi catalysts for hydrogen production

Green chemistry : an international journal and green chemistry resource : GC, 2015-05, Vol.17 (5), p.2745-2749

2015

Volltextzugriff (PDF)

Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres

European journal of cancer (1990), 2017-11, Vol.85, p.15-22

2017

Volltextzugriff (PDF)

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study

Breast cancer research and treatment, 2017-04, Vol.162 (3), p.479-488

2017

Volltextzugriff (PDF)

Determining Excitation-Energy Transfer Times and Mechanisms from Stochastic Time-Dependent Density Functional Theory

The journal of physical chemistry. B, 2013-11, Vol.117 (46), p.14408-14419

2013

Volltextzugriff (PDF)

The effect of EUSOMA certification on quality of breast cancer care

European journal of surgical oncology, 2015-10, Vol.41 (10), p.1423-1429

2015

Volltextzugriff (PDF)

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

Annals of oncology, 2012-09, Vol.23 (9), p.2259-2264

2012

Volltextzugriff (PDF)

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Annals of oncology, 2017-11, Vol.28 (11), p.2768-2772

2017

Volltextzugriff (PDF)

1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial

European journal of cancer (1990), 2015-09, Vol.51, p.S311-S311

2015

Volltextzugriff (PDF)

P246 Risk assessment by St.Gallen 2013 recommendation and Oncotype DX® : results from the WSG PlanB trial

Breast (Edinburgh), 2015-03, Vol.24, p.S110-S110

2015

Volltextzugriff (PDF)

P231 Luminal subtypes vs. early Ki-67 response and Oncotype DX® in early breast cancer: WSG-ADAPT study

Breast (Edinburgh), 2015-03, Vol.24, p.S104-S105

2015

Volltextzugriff (PDF)

Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial

Annals of oncology, 2010-07, Vol.21 (7), p.1430-1435

2010

Volltextzugriff (PDF)

Diagnostic accuracy of fused positron emission tomography/ magnetic resonance mammography: initial results

British journal of radiology, 2011-02, Vol.84 (998), p.126-135

2011

Volltextzugriff (PDF)

The Prognostic Significance of Human Epidermal Growth Factor Receptor Correlations in Squamous Cell Cervical Carcinoma

Anticancer research, 2007-03, Vol.27 (2), p.959-963

2007

Volltextzugriff (PDF)

Optimizing the Clinical Management of Gynecological and Breast Cancer via Online Tumor Conferences

Anticancer research, 2011-08, Vol.31 (8), p.2669-2673

2011

Volltextzugriff (PDF)

Orbital localization, charge transfer, and band gaps in semilocal density-functional theory

Physical review letters, 2013-07, Vol.111 (3), p.036402-036402, Article 036402

2013

Volltextzugriff (PDF)

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Annals of oncology, 2019-08, Vol.30 (8), p.1279-1288

2019

Volltextzugriff (PDF)

1 – 25 von 1.230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(998)
Mit Volltextzugriff
(1.062)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(683)
Life Sciences & Biomedicine
(424)
Humans
(220)
Physical Sciences
(210)
Oncology
(188)
Female
(178)
Breast Cancer
(138)
Physics
(132)
Technology
(129)
Middle Aged
(113)
Adult
(99)
Chemistry
(91)
Aged
(88)
Tumors
(77)
Materials Science
(68)
Breast Neoplasms - Drug Therapy
(66)
Breast Neoplasms - Pathology
(65)
Biological And Medical Sciences
(64)
Chemotherapy
(63)
Materials Science, Multidisciplinary
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial

New method for producing power electronic circuit boards by cold-gas spraying and investigation of adhesion mechanisms

The use of ultrasonic cavitation for near-surface structuring of robust and low-cost AlNi catalysts for hydrogen production

Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study

Determining Excitation-Energy Transfer Times and Mechanisms from Stochastic Time-Dependent Density Functional Theory

The effect of EUSOMA certification on quality of breast cancer care

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial

P246 Risk assessment by St.Gallen 2013 recommendation and Oncotype DX® : results from the WSG PlanB trial

P231 Luminal subtypes vs. early Ki-67 response and Oncotype DX® in early breast cancer: WSG-ADAPT study

Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial

Diagnostic accuracy of fused positron emission tomography/ magnetic resonance mammography: initial results

The Prognostic Significance of Human Epidermal Growth Factor Receptor Correlations in Squamous Cell Cervical Carcinoma

Optimizing the Clinical Management of Gynecological and Breast Cancer via Online Tumor Conferences

Orbital localization, charge transfer, and band gaps in semilocal density-functional theory

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Suchergebnisse filtern